Winan van Houdt: Bi-annual meeting of the soft tissue and bone sarcoma group of the EORTC
Winan van Houdt, Surgical Oncologist at Antoni van Leeuwenhoek/Netherlands Cancer Institute, shared a post on LinkedIn:
“Bi-annual meeting of the soft tissue and bone sarcoma group (STBSG) of the EORTC – European Organisation for Research and Treatment of Cancer at the University in the beautiful city of Torino, Italy.
We continued discussing new directions and trial ideas for sarcoma research, but also the challenges we face due to the lack of funding resources and pharma support for rare cancers like sarcoma. Also updating the group about the progress we make with our global trial in retroperitoneal sarcoma STRASS2/STREXIT2.
An inspiring program of high quality, thanks to local hosts Lorenzo D’Ambrosio and Alessandra Merlini, the secretary of the group Sylvia Stacchiotti, and all the speakers. As the chair of the group, I am grateful to have these amazing colleagues around me to lead this group together.
And we said goodbye to Laura de Meulemeester, for all her work for the STBSG in the last 7 years now that she is leaving us for a new challenge.”
More posts featuring Winan van Houdt.
Winan van Houdt is a surgical oncologist at Antoni van Leeuwenhoek/Netherlands Cancer Institute, specializing in rare cancers such as GIST, soft tissue sarcomas (retroperitoneal, intra-abdominal, and extremity), melanoma, desmoid tumors, and non-melanoma skin cancers.
He serves as the Program Coordinator for Rare Cancers at the Netherlands Cancer Institute and chairs the Soft Tissue and Bone Sarcoma Group (STBSG) at the EORTC. Van Houdt is also a member of the Scientific Steering Committee for the Sarcoma Track at ESMO 2024.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023